2018 Texas Medicaid Preferred Drug List, Effective 1/25
Date: 12/29/17
Effective Thursday, January 25, 2018, Texas Medicaid will implement the semi-annual update of the Vendor Drug Program’s (VDP) Medicaid Preferred Drug List (PDL). The update is based on changes presented at the Drug Utilization Review (DUR) Board meetings in July and November of 2017. As a reminder, Superior follows the Texas Medicaid VDP Formulary and the PDL.
Noteworthy changes in the January 2018 PDL are listed below:
Drug | Board Reviewed | Prior to January 25, 2018 | Effective January 25, 2018 |
|---|---|---|---|
Exelon | 7/2017 | Preferred | Non-preferred |
Memantine tablet | 7/2017 | Preferred | Non-preferred |
Rivastigmine | 7/2017 | Non-preferred | Preferred |
Suprax | 7/2017 | Preferred | Non-preferred |
Emflaza suspension and tablet | 7/2017 | Not previously reviewed | Non-preferred |
Farxiga (oral) | 7/2017 | Non-preferred | Preferred |
Invokamet XR (oral) | 7/2017 | Not previously reviewed | Non-preferred |
Invokamet (oral) | 7/2017 | Preferred | Non-preferred |
Invokana (oral) | 7/2017 | Preferred | Non-preferred |
Jardiance (oral) | 7/2017 | Non-preferred | Preferred |
Synjardy (oral) | 7/2017 | Non-preferred | Preferred |
Synjardy XR (oral) | 7/2017 | Not previously reviewed | Non-preferred |
Makena MDV | 7/2017 | Not previously reviewed | Preferred |
Makena SDV | 7/2017 | Not previously reviewed | Preferred |
Diclegis | 11/2017* | Preferred | Non-preferred |
Abilify | 11/2017* | Preferred | Non-preferred |
Aripiprazole | 11/2017* | N/A | Preferred |
Strattera | 11/2017* | Preferred | Non-preferred |
Atomoxetine | 11/2017* | N/A | Preferred |
Latuda | 11/2017* | Preferred | Non-preferred |
* meeting decisions are pending
Providers may also review upcoming changes in the following VDP notification: https://www.TxVendorDrug.com/about/news/2017/12/january-2018-texas-medicaid-preferred-drug-list.
To find a full list covered drugs, please visit the VDP’s website: https://www.TxVendorDrug.com/.